# Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy?

> **NCT04080505** · PHASE3 · TERMINATED · sponsor: **Columbia University** · enrollment: 29 (actual)

## Conditions studied

- Graves Disease

## Interventions

- **DRUG:** SSKI- Potassium Iodide

## Key facts

- **NCT ID:** NCT04080505
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02-10
- **Primary completion:** 2023-03-03
- **Final completion:** 2023-03-03
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04080505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04080505, "Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04080505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*